DexCom Inc. (DXCM)
NASDAQ: DXCM
· Real-Time Price · USD
82.82
-0.17 (-0.20%)
At close: Jun 12, 2025, 3:59 PM
81.55
-1.53%
Pre-market: Jun 13, 2025, 08:58 AM EDT
-0.20% (1D)
Bid | 81.4 |
Market Cap | 32.47B |
Revenue (ttm) | 4.15B |
Net Income (ttm) | 535.2M |
EPS (ttm) | 1.33 |
PE Ratio (ttm) | 62.27 |
Forward PE | 32.7 |
Analyst | Buy |
Ask | 82.99 |
Volume | 2,038,571 |
Avg. Volume (20D) | 4,033,858 |
Open | 82.89 |
Previous Close | 82.99 |
Day's Range | 82.02 - 83.61 |
52-Week Range | 57.52 - 117.91 |
Beta | 1.46 |
About DXCM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DXCM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DXCM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-0.23%
Shares of diabetes stocks are trading lower follow...
Unlock content with
Pro Subscription
2 months ago
+0.69%
Dexcom shares are trading higher after the company received FDA clearance for its G7 15-day continuous glucose monitoring system.